Browse > Article
http://dx.doi.org/10.5142/JGR.2009.33.2.089

Ginseng as a Complementary and Alternative Medicine for Postmenopausal Symptoms  

Shim, Myeong-Kuk (College of Life Science, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University)
Lee, Young-Joo (College of Life Science, Institute of Biotechnology, Department of Bioscience and Biotechnology, Sejong University)
Publication Information
Journal of Ginseng Research / v.33, no.2, 2009 , pp. 89-92 More about this Journal
Abstract
Ginseng is a popular herbal medicine that has been used for thousands of years. A number of its components have been isolated and characterized, including ginsenosides, polysaccharides, peptides, polyacetylenic alcohols, and fatty acids. The lipophilic characteristics of ginsenosides have raised the possibility of their efficacy as steroid hormones. Several in-vitro studies have reported their pharmacological function as steroid hormones, especially estrogen, but no human study to date has confirmed their efficacy as alternatives to synthetic estrogen.
Keywords
ginseng; complementary medicine; postmenopausal symptoms;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch. Intern. Med. 166: 1453-65 (2006)   DOI   ScienceOn
2 Hartley DE,Elsabagh S, File SE. Gincosan (a combination of Ginkgobiloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women. Nutr. Neurosci. 7: 325-33 (2004)   DOI   ScienceOn
3 GlazierMG, BowmanMA. A reviewof the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Intern. Med. 161: 1161-1172 (2001)   DOI   ScienceOn
4 Warnecke G Influencing menopausal symptoms with a phytotherapeutic agent: successful therapy withcirnicifuga monoextract. Med. Welt. 36: 871-874 (1985)
5 Stoll W. Phytopharmacon influences atrophic vaginal epithetlium: double-blind study: cimicifuga versus estrogenic substances. Therapeutikon. 1: 23-31 (1987)
6 E Lehrnann-Willenbrock E, Riedel HH. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zentralbl. Gynakol. 110: 611-618 (1988)   ScienceOn
7 Jacobson JS, Troxel AS, Evans J. Randomized trial of black cohoshfor the treatment of hot flashes amongwomenwith a history of breastcancer. J. Clin. Oncol. 19:2739-2745 (2001)   DOI   ScienceOn
8 FarhatMY, LavigneMC, Ramwell PW. The vascularprotective effects of estrogen. FASEB. J. 10: 615-624 (1996)   DOI   ScienceOn
9 Kim HS, Zhang YR, Fang LH, Lee MK. Effects of ginsenosides on bovine adrenal tyrosine hydroxylase. J. Ethnopharmacal. 66: 107-111 (1999)   DOI   ScienceOn
10 Ivanova T, Beyer C. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J. Neurobiol. 54, 638-647 (2003)   DOI   ScienceOn
11 MishraSI, Dickerson V, Najm W. Phytoestrogens and breast cancer prevention: what is the evidence? Am J. Obstet. Gynecol. 188: 66-70 (2003)   DOI   ScienceOn
12 Yoon M, Lee H, Jeong S, Kim J.J., Nicol CJ. Nam KW, Kim M, Cho Bo, Oh Gr. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng. Brl. Pharmacol. 138: 1295-1302 (2003)   DOI   ScienceOn
13 Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, YooYB, Ko YC, Jun WT, Park HJ. Possible role of ginsenoside RbI on regulation of rat liver triglycerides. Biol. Pharm. Bull. 25: 457-460 (2002)   DOI   ScienceOn
14 Nemmani KV, Ramarao P. Ginsenoside Rf potentiates U50,488H-induced analgesia and inhibits tolerance to its analgesia in mice. Life Sci. 72: 759-768 (2003)   DOI   ScienceOn
15 Scott GI, Colligan PB, Ren BH, Ren J. Ginsenosides $Rb_1$ and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br J Pharmacol. 134: 1159-1165 (2001)   DOI   ScienceOn
16 Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause. 9: 145-150(2002)   DOI   ScienceOn
17 Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol. Physiol. 23: 728-732 (1996)   DOI   ScienceOn
18 Ernst E, Cassileth BR.How usefulare unconventional cancer treatments? Eur J. Cancer. 35: 1608-1613 (1999)   DOI   ScienceOn
19 Choi S, Jung SY, Ko YS, Koh SR, Rhim H, Nah sv Functional expression of a novel ginsenoside Rf binding protein from rat brainmRNAin Xenopus laevis oocytes. Mol. Pharmacal. 61: 928-935 (2002)   DOI   ScienceOn
20 Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann. Intern. Med. 137: 805-813 (2002)   DOI   ScienceOn
21 Hoffman GE, Zup SP. Good versus evil: changing the approach to hormone replacement therapy. Endocrinology. 144: 468-4699 (2003)
22 Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science. 304: 1269-1273 (2004)   DOI   ScienceOn
23 Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, Haines CJ, Chan TY, Li M, Sham A. Comparison of Puerarialobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause. 10: 352-361 (2003)   DOI   ScienceOn
24 Cassidy A. Potential risks and benefits of phytoestrogen-rich diets. Int J .Vitam. Nutr. Res. 73: 120-126 (2003)   DOI   ScienceOn
25 Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 288: 321-333 (2002)   DOI   ScienceOn
26 Lee YJ, Gorski J. Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc Natl Acad Sci USA. 93: 15180-15184 (1996)   DOI   ScienceOn
27 Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta. Med. 69: 589-599 (2003)   DOI   ScienceOn
28 Joo HK, Lee SK, Kim HS, Song YJ, Kang O, Park JB, Lee KH, Cho EJ, Lee JR, Seong IW, Kim SH, Cho CH, Jeon BH. Korean red ginseng extract inhibits tumor necrosis factor-alpha-induced monocyte adhesion in the humanendothelial cells. J Ginseng Res. 3: 244-249 (2008)
29 Saiki Ikuo. In vivo anti-metastatic action of Ginseng Saponins is based on their intestinal bacterial metabolites after oral administration. J Ginseng Res. 1: 1-13 (2007)   과학기술학회마을
30 Lee JH, Choi SH, Nah sv Studyon life span extension efficacy by korean red ginseng. J Ginseng Res. 4: 210-216 (2007)
31 Attele AS, Wu JA, Yuan CS. Ginseng Pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693 (1999)   DOI   ScienceOn
32 Yuan CS, Wu JA. Ginsenoside variability in American ginseng samples. Am J. Clin. Nut. 75: 600-601 (2002)   DOI
33 Xing YZ, ShangHC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modem pharmacological experiment and clinical trials. Phytother Res. 22: 851-858 (2008)   DOI   ScienceOn
34 Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extracton quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group.: Int J. Clin. Pharmacol. Res. 19: 89-99 (1999)   ScienceOn
35 Viereck V, Emons G, Wuttke W. Black cohosh: just another phytoestrogen? Trends. Endocrinol. Metab. 16: 214-221 (2005)   DOI   ScienceOn
36 Davis VL,Jayo MJ, Ho A, Kotlarczyk MP, HardyM.L, Foster WG, Hughes CL. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2. Cancer. Res. 68: 8377-83 (2008)   DOI   ScienceOn
37 Wong VC, Lim CE, Luo X, Wong WS. Current alternative and complementary therapies used in menopause. : Gynecol. Endocrinol. 25: 166-74 (2009)   DOI   ScienceOn
38 Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I. Effect of Korean red ginseng on psychological functions in patients with severeclimacteric syndromes. Int J. Gynaecol. Obstet. 67: 169-74 (1999)   DOI   ScienceOn
39 Liske E, Hanggi W, Henneicke-von ZepelinHH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a uniqueextract of black cohosh (Cimicifugae racemosae rhizoma): a six-month clinical study demonstrates no systemic estrogenic effect. J. Womens Health Gend Based. Med. 11: 163-174 (2002)   DOI   ScienceOn
40 Liske E, Wtistenberg P. Therapy of climacteric complaints with Cimicfuga racemosa: a herbal medicine with clinically provenevidence. Poster Presentation. North American Menopause Society (1998)
41 Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 versusconjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 44: S67-S77 (2003)   DOI   ScienceOn
42 Duda RB, Zhong YZ, Navas V, Li MZC, Toy BR. Alavarez JG. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J. Surg. Oncol. 72: 230-239 (1999)   DOI   ScienceOn
43 Chan RY, Chen WF, Dong A, Guo D, Wong MS. Estrogenlikeactivity of ginsenoside Rgl derived from Panax notoginseng. J. Clin. Endocrinol. Metab. 87: 3691-3695 (2002)   DOI   ScienceOn
44 Lau WS, Chen WF, Chan RY, Guo DA, Wong MS. Mitoenactivated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rgl in human breast cancer(MCF-7) cells. Brl. Pharmacol. 156: 1136-1146 (2009)   DOI   ScienceOn
45 Lee Y, Jin Y,Lim W, Ji S, Choi S, Jang S, Lee S. A ginsenoside-Rhl, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J. Steroid. Biochem. Mol. Biol, 84: 463-468 (2003)   DOI   ScienceOn